Innospec Inc.
IOSP Basic Materials Specialty Chemicals
Innospec Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 3.65% from fiscal 2024.
- Revenue
- +7.17%
- EPS
- +146.7%
- Free cash flow
- −88.7%
Quarter to September 2026, against a year earlier
Follow IOSP
Alert me
Innospec Inc. (IOSP) P/E ratio
As of 5 November 2026, Innospec Inc. (IOSP) trades at a P/E ratio of 13.9×. Over the past ten years it has ranged from 0.0× (December 2025) to 138× (April 2021); the current reading is higher than 17% of that period. That is below the Specialty Chemicals industry median of 24.5× and below the Basic Materials sector median of 19.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 16.4× | (78.75%) |
| FY2024 | 77.0× | 252.79% |
| FY2023 | 21.8× | 12.94% |
| FY2022 | 19.3× | (19.17%) |
| FY2021 | 23.9× | (69.18%) |
| FY2020 | 77.5× | 243.35% |
| FY2019 | 22.6× | 27.26% |
| FY2018 | 17.7× | (36.19%) |
| FY2017 | 27.8× | 36.06% |
| FY2016 | 20.4× | 86.68% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 16.8× | 1.37% |
| Jun 2026 | 16.6× | 4.43% |
| Mar 2026 | 15.9× | (2.94%) |
| Dec 2025 | 16.4× | — |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CC The Chemours Company compare | n/m |
| MTX Minerals Technologies Inc. compare | n/m |
| FUL H. B. Fuller Company compare | 13.8× |
| IOSP Innospec Inc. | 13.9× |
| KWR Quaker Houghton compare | 27.2× |
| WDFC WD-40 Company compare | 37.0× |
| NGVT Ingevity Corporation compare | 42.0× |
| SCL Stepan Company compare | 361× |
| STDN Standard Nuclear Inc compare | — |
| Specialty Chemicals industry median | 24.5× |
| Basic Materials sector median | 19.0× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)